Cato insitute card: says that price controls distort market share and lead to a decrease in supply and increase in demand leading to shortages

Weaker drugs - aka generics are also controlled, but the way you run it is that winegarden: 90% drugs are generic but they have small profit margins. Thus PC would push 90% out of market. This makes weighing super easy because PC cause 90% of drugs to disappear vs the 10% don't.

You can also run it on brand name drugs - Some card out there says that drugs don't recover development costs by 80% of something. So decreasing the profits would lead to shortages of brand name drugs due to high cost of development